Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: New biomarkers of gestational ethanol exposure?

Therapeutic Drug Monitoring

Volumn 30, Issue 6, 2008, Pages 725-732

  Morini, Luca ^a   Marchei, Emilia ^b   Pellegrini, Manuela ^b   Groppi, Angelo ^a   Stramesi, Cristiana ^a   Vagnarelli, Federica ^c   Garcia Algar, Oscar ^d   Pacifici, Roberta ^a   Pichini, Simona ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d HOSPITAL DEL MAR   (Spain)

Author keywords

Ethyl glucuronide; Ethyl sulfate; LC MS; Therapeutic drug monitoring

Indexed keywords

ACETONITRILE; ALCOHOL; BIOLOGICAL MARKER; ETHYL GLUCURONIDE; ETHYL SULFATE; UNCLASSIFIED DRUG;

ACCURACY; ALCOHOL METABOLISM; ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; HUMAN; LIQUID CHROMATOGRAPHY; MECONIUM; METABOLITE; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ETHANOL; FEMALE; GLUCURONATES; HUMANS; INFANT, NEWBORN; MECONIUM; PREGNANCY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; SULFURIC ACID ESTERS; TANDEM MASS SPECTROMETRY;

EID: 57749113459     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31818b2fd9     Document Type: Article

References (16)

1. Ostrea EM, Parks P, Brady M. Rapid isolation and detection of drugs in meconium of infants of drug-dependent mothers. Clin Chem. 1988;34:2372-2373.
2. Pichini S, Altieri I, Zuccaro P, et al. Meconium as a matrix. Clin Pharmacokinet. 1996;31:8.
3. Pichini S, Puig C, Zuccaro P, et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project." Forensic Sci Int. 2005;153:59-65.
4. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse - the Canadian experience. Ther Drug Monit. 1999;21:644-646.
5. Bearer CF, Jacobson JL, Jacobson SW, et al. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr. 2003;143:463-469.
6. Moore C, Jones J, Lewis D, et al. Prevalence of fatty acid ethyl esters in meconium specimens. Clin Chem. 2003;49:133-136.
7. Ostrea EM, Hernandez JD, Bielawski DM, et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin Exp Res. 2006;30:1152-1159.
8. Pichini S, Pellegrini M, Gareri J, Koren J, et al. Alarming prevalence of fetal alcohol exposure in a Mediterranean City. Ther Drug Monit. 2008;30:249-254.
9. Chan D, Bar-Oz B, Pellerin B, et al. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 2003;25:271-278.
10. Lemoine P, Harousseau H, Borteyru JP, et al. Children of alcoholic parents - observed anomalies: discussion of 127 cases. Ther Drug Monit. 2003;25:132-136.
11. Koren G, Nulman I, Chudley AE, et al. Fetal alcohol spectrum disorder. CMAJ. 2003;169:1181-1185.
12. Gareri J, Klein J, Koren G. Drugs of abuse testing in meconium. Clin Chim Acta. 2006;366:101-111.
13. Politi L, Leone F, Morini L, et al. Bioanalytical procedures for determination of conjugates or fatty acid esters of ethanol as markers of ethanol consumption: a review. Anal Biochem. 2007;368:1-16.
14. Politi L, Morini L, Groppi A, et al. Direct determination of the ethanol metabolites ethyl glucuronide and ethyl sulfate in urine by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom. 2005;19:1321-1331.
15. Politi L, Morini L, Leone F, et al. Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption? Addiction. 2006;101:1408-1412.
16. Pragst F, Yegles M. Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy? Ther Drug Monit. 2008;30:255-263.